PMID- 36643781
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230117
IS  - 2631-4940 (Electronic)
IS  - 2631-4940 (Linking)
VI  - 5
IP  - 1
DP  - 2023
TI  - Exploring procedure duration and risk for serious adverse events during 
      congenital cardiac catheterization.
PG  - e000142
LID - 10.1136/bmjsit-2022-000142 [doi]
LID - e000142
AB  - OBJECTIVES: While procedure length is considered an important metric for 
      cardiothoracic surgical procedures, the relationship between procedure length and 
      adverse events (AEs) in congenital cardiac catheterizations has little published 
      data available. Furthermore, most existing congenital cardiac catheterization 
      risk prediction models are built on logistic regression models. This study aimed 
      to characterize the relationship between case length and AE occurrence in 
      congenital cardiac catheterization while adjusting for known risk factors and to 
      investigate the potential role of non-linear analysis in risk modeling. DESIGN: 
      Age, case type, and procedure duration were evaluated for relationships with the 
      primary outcome using logistic regression. Non-linearity of the associations with 
      continuous risk factors was assessed using restricted cubic spline 
      transformations. SETTING AND PARTICIPANTS: All diagnostic and interventional 
      congenital cardiac catheterization cases performed at Boston Children's Hospital 
      between January 1, 2014 and October 31, 2019 were analyzed. MAIN OUTCOME MEASURE: 
      The primary outcome was defined as the occurrence of any clinically significant 
      (level 3/4/5) AE. RESULTS: A total of 7011 catheterization cases met inclusion 
      criteria, with interventional procedures accounting for 68% of cases. Median case 
      duration was 97 min. A multivariable model including age, procedure type, and 
      case duration showed a significant relationship between case duration and AE 
      occurrence (OR 1.07 per 10 min increase, 95% CI 1.06 to 1.09, p<0.001). 
      CONCLUSIONS: This study demonstrated the importance of procedure duration as a 
      potential frontier for procedure risk management. Better understanding of the 
      role of procedure duration in cardiac catheterizations may provide opportunities 
      for quality improvement in patient safety and resource planning.
CI  - (c) Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Yeh, Mary J
AU  - Yeh MJ
AUID- ORCID: 0000-0001-9496-3462
AD  - Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
FAU - Lydon, Elizabeth
AU  - Lydon E
AD  - The MITRE Corporation, McLean, Virginia, USA.
FAU - Gauvreau, Kimberlee
AU  - Gauvreau K
AD  - Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
FAU - Jenkins, Kathy J
AU  - Jenkins KJ
AD  - Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
FAU - Slater, David
AU  - Slater D
AD  - The MITRE Corporation, McLean, Virginia, USA.
FAU - Bergersen, Lisa
AU  - Bergersen L
AD  - Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20230110
PL  - England
TA  - BMJ Surg Interv Health Technol
JT  - BMJ surgery, interventions, & health technologies
JID - 101764673
PMC - PMC9835933
OTO - NOTNLM
OT  - Cardiac Devices
OT  - Methodology
OT  - Outcomes Research
OT  - Patient Outcome Assessment
COIS- Competing interests: None declared.
EDAT- 2023/01/17 06:00
MHDA- 2023/01/17 06:01
PMCR- 2023/01/10
CRDT- 2023/01/16 02:46
PHST- 2022/03/30 00:00 [received]
PHST- 2022/11/15 00:00 [accepted]
PHST- 2023/01/16 02:46 [entrez]
PHST- 2023/01/17 06:00 [pubmed]
PHST- 2023/01/17 06:01 [medline]
PHST- 2023/01/10 00:00 [pmc-release]
AID - bmjsit-2022-000142 [pii]
AID - 10.1136/bmjsit-2022-000142 [doi]
PST - epublish
SO  - BMJ Surg Interv Health Technol. 2023 Jan 10;5(1):e000142. doi: 
      10.1136/bmjsit-2022-000142. eCollection 2023.